# Stacking Tesamorelin and MOTS-C with Retatrutide: A Complete Protocol Guide
If you're already running Retatrutide and seeing results, the natural question is: what compounds can I add to accelerate body composition changes? Two peptides consistently come up in this conversation — Tesamorelin and MOTS-C.
This guide covers why these specific compounds pair well with Reta, the order to add them, dosing protocols, and what to expect phase by phase.
Why These Three Work Together
Retatrutide, Tesamorelin, and MOTS-C target different pathways that compound on each other:
Retatrutide is a triple-agonist GLP-1/GIP/glucagon receptor agonist. It reduces appetite, slows gastric emptying, and — uniquely among GLP-1s — activates glucagon signaling which directly promotes fat oxidation in the liver. The glucagon component is why many users report better visceral fat reduction vs tirzepatide.
Tesamorelin is a growth hormone-releasing hormone (GHRH) analog. It stimulates your pituitary to release endogenous GH in a natural pulsatile pattern. Clinical trials (particularly the FDA approval studies for HIV lipodystrophy) demonstrated significant visceral fat reduction without the risks of exogenous GH. It's the only FDA-approved compound specifically for visceral fat.
MOTS-C is a mitochondria-derived peptide that activates AMPK — your body's energy sensor. It improves mitochondrial function, enhances fat oxidation during exercise, and has exercise-mimetic properties. For active people, MOTS-C often provides noticeable energy and endurance improvements.
The synergy:
- Reta handles appetite suppression and direct glucagon-mediated fat burning
- Tesamorelin targets visceral fat specifically through the GH axis
- MOTS-C improves cellular energy production and fat utilization
- You've found your stable Reta dose (typically 1-3mg weekly)
- GLP-1 side effects have subsided or are manageable
- Weight loss or body comp changes are proceeding as expected
- You want to accelerate visceral fat loss or improve training performance
- Synergy with Reta's fat loss mechanisms. Tesamorelin's visceral fat effect compounds directly with Reta's glucagon signaling. You'll see body composition changes faster with this pair than either alone.
- Easier to assess. Tesamorelin effects (sleep quality improvement, subtle body recomp, potential water retention) appear within 2-3 weeks. You can confirm it's working before adding MOTS-C.
- No overlap with Reta side effects. Tesamorelin side effects (joint stiffness, mild edema) don't overlap with GLP-1 side effects (nausea, fatigue). Clean troubleshooting if something feels off.
- Start at 500mcg daily, morning injection (subQ)
- Can increase to 1mg daily after 2 weeks if tolerated
- Some prefer 5mg 2-3x weekly instead of daily — both protocols work
- Standard: 0.25mg → 0.5mg → 1mg → 2mg → 3mg (weekly increases)
- Most users stabilize between 1-3mg weekly
- No need to adjust Reta dose when adding Tesamorelin or MOTS-C
- Starting dose: 1mg daily
- Maintenance dose: 2mg daily
- Timing: Evening, before bed (aligns with natural GH pulsatility)
- Injection: SubQ, abdomen or thigh
- Cycle length: 12 weeks on, 4 weeks off (standard)
- Option A (daily): 500mcg-1mg daily, morning
- Option B (pulsed): 5mg 2-3x weekly
- Timing: Morning preferred (aligns with metabolic activity)
- Injection: SubQ, any site
- Cycle length: 8-12 weeks on, 4 weeks off (receptor sensitivity consideration)
- Improved sleep quality (deeper, more restorative)
- Possible mild water retention or joint stiffness
- Subtle recovery improvement between workouts
- Sleep benefits continue
- Beginning to see body composition shifts (less bloated, more definition)
- Appetite stable (Reta handles this)
- Energy levels stabilize or improve
- Training endurance increases (especially cardio)
- Fat loss may accelerate
- Visible visceral fat reduction
- Improved muscle definition and separation
- Better workout performance and recovery
- Body recomposition effects compound
- Joint stiffness: Temporary, usually subsides by week 3. Stay hydrated, consider magnesium.
- Water retention: Mild, GH-related. Usually stabilizes. Not the same as Reta's dose-related retention.
- Injection site reactions: Rotate sites, inject at room temperature.
- Mild fatigue days 1-3: Common, transient. MOTS-C affects energy systems before optimizing them.
- Injection site discomfort: Minimal. SubQ technique matters.
- Rare GI effects: Less common than BPC-157 GI sensitivity.
- Monitor for cumulative water retention (Reta + Tesamorelin both can cause this)
- Track subjective energy (MOTS-C should improve this after initial adjustment)
- If something feels off, don't adjust everything — pause one compound and reassess
Three different mechanisms, one goal: accelerated body recomposition with preserved (or increased) muscle.
When to Start Stacking
Don't add Tesamorelin or MOTS-C on day one of Reta. Here's why timing matters:
Wait until you're stable on Reta (4-6 weeks minimum). The first month of any GLP-1 involves titration, side effect management, and establishing your baseline response. Adding other compounds during this window makes troubleshooting impossible. If you experience nausea, fatigue, or GI issues, you won't know which compound is responsible.
Good indicators you're ready to stack:
The Stacking Order: Tesamorelin First
If you're adding both compounds, start with Tesamorelin:
Week 1-2: Add Tesamorelin 1mg daily (evening injection, before bed)
Week 3-4: Increase to 2mg daily if tolerated
Week 5-6: Add MOTS-C 500mcg daily (morning, any time)
Why Tesamorelin First
When to Add MOTS-C
Add MOTS-C 2-3 weeks after you're stable on Tesamorelin:
MOTS-C effects take 2-3 weeks to become noticeable (improved training endurance, steadier energy levels). It's a more subtle compound than Tesamorelin or Reta.
Dosing Protocols
Retatrutide (existing protocol)
Maintain your current titration:
Tesamorelin
MOTS-C
Daily Schedule Example
| Time | Compound | Dose | Notes |
| Morning | MOTS-C | 500mcg subQ | Before breakfast or with first meal |
| Evening (before bed) | Tesamorelin | 2mg subQ | 30+ min after last meal |
| Weekly (any day) | Retatrutide | Per titration | SubQ, same day each week |
This schedule keeps compounds separated and aligns with natural physiology (MOTS-C with daytime metabolic activity, Tesamorelin with nighttime GH pulsing).
What to Expect: Timeline
Weeks 1-2 (Tesamorelin only)
Weeks 3-4
Weeks 5-6 (add MOTS-C)
Weeks 8-12
Side Effects and Management
Tesamorelin
MOTS-C
Combined Stack
Frequently Asked Questions
Q: Can I start Tesamorelin and MOTS-C at the same time?
You can, but I don't recommend it. Starting one at a time (2-3 weeks apart) gives you clean data on what each compound contributes. If you experience side effects, you'll know which compound to adjust.
Q: Do I need to increase my Reta dose when adding these compounds?
No. Your Reta titration should be based on appetite suppression and side effect tolerance, not on what else you're stacking. Most people stabilize at 1-3mg weekly regardless of additional compounds.
Q: What if I can only afford one compound?
Tesamorelin if visceral fat is your primary concern. MOTS-C if training performance and energy are the priority. If budget allows, Tesamorelin has a stronger body composition effect for most users.
Q: How long should I run this stack?
12 weeks is a reasonable cycle length. After 12 weeks, cycle off Tesamorelin for 4 weeks (standard protocol), and you can choose to continue or pause MOTS-C. Many people run 2-3 full cycles per year.
Q: What about Ipamorelin instead of Tesamorelin?
CJC-1295/Ipamorelin is a solid alternative GH secretagogue stack, but Tesamorelin has stronger clinical evidence specifically for visceral fat. Ipamorelin tends to be cheaper and more available. If budget is a constraint, CJC+Ipa is a reasonable substitute.
Q: Will this stack help me build muscle?
Indirectly. Tesamorelin supports GH-mediated muscle protein synthesis. MOTS-C improves workout capacity. Reta can reduce muscle catabolism through improved metabolic signaling. But for significant muscle building, you still need progressive overload training and adequate protein (1.5-2g per kg bodyweight).
Q: Where do I source these compounds?
For US-based sourcing, American Peptide Research carries Tesamorelin, MOTS-C, and research peptides: americanpeptideresearch.com/ref/126/
---
Track Your Full Protocol
Running Reta + Tesamorelin + MOTS-C with different frequencies and timing? PeptIQ is built for exactly this — log doses, track subjective response, and see what's actually moving the needle.
Download PeptIQ — free to start.
